Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

PXYN (Praxsyn Corporation) News

Discussion in 'Penny Stocks' started by Giants1967, Jan 14, 2020.

  1. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
    WEST PALM BEACH, Florida, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Praxsyn (OTC:pXYN, the “Company”) is pleased to announce that it is currently processing portfolios for funding with its funding partner and the first is already in underwriting, with another expected to follow in approximately ten days; projected revenue to Praxsyn on these portfolios exceeds $500,000.

    Frank Brady, the Company’s CEO stated, “These new portfolios should generate substantial revenue this quarter, with more to follow.” He continued, “2019 was a difficult year, obtaining a funding partner, ironing out bugs with process and personnel, but now it seems that our systems are in place and we plan to grow revenue at a rapid pace into 2020 and beyond.”

    About Praxsyn Corporation

    Headquartered in West Palm Beach, Florida, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyncorp.com.

    With a mid-market private equity firm that invests in growth companies, recapitalizes or backs new executives.
     
  2. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
    Praxsyn (OTC:pXYN, the “Company”) is pleased to announce that it has appointed Daniel Oswald as Chief Financial Officer for Praxsyn Corporation and Praxsyn Capital.

    Mr. Oswald has been a successful finance and operations professional for nearly 20 years and brings experience in finance, accounting, systems, and human resources to the Company. Mr. Oswald attended The Wharton School at the University of Pennsylvania from 1999-2002 where he was awarded a Bachelor of Science in Economics degree, Cum Laude, with concentrations in Finance and Accounting. While at Wharton, he was both a Joseph Wharton and a Benjamin Franklin Scholar. Mr. Oswald began his career in the Mergers & Acquisitions group of Merrill Lynch’s Investment Banking Division in New York. He returned to California where he worked in corporate finance roles for PC Mall, Countrywide/Bank of America, and Prospect Mortgage. Since his last corporate role, Mr. Oswald has run his own consulting firm, which in the past two years has increased revenues 100%.
     
  3. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
    Praxsyn (OTC:pXYN, the “Company”) is pleased to announce that it has signed two new rep groups with multiple reps, in multiple states, to bring new sales to our wholly owned subsidiary, Praxsyn Capital.

    The new rep groups will assist us in developing training materials in order to allow us to expand our sales staff nationwide

    Praxsyn is also exploring the development of computer-based training (“CBT”) systems to train new reps on how to source new portfolios, and other CBT systems to train providers in onboarding portfolios for more rapid funding.

    Finally, Praxsyn is exploring the development of CBT Continuing Education (“CE”) software to help doctors and lawyers learn about the benefits of financing portfolios for their patients and clients.

    About Praxsyn Corporation
     
  4. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
  5. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
    $PXYN NEWS!
    Praxsyn (OTC: PXYN, the “Company”) is pleased to announce that its subsidiary, Mesa Pharmacy has resumed collections on its vast portfolio of existing Workers’ Compensation receivables.

    Mesa, a wholly owned subsidiary of the Company, provided specialized prescription compounding for Workers’ Compensation claims in the State of California.

    During 2014 and 2015, Mesa generated over $200,000,000 in gross revenues from compounded prescriptions. Although Mesa routinely sold its receivables, it currently owns a portfolio of receivables with a face value greater than $50,000,000.

    During 2017, the State of California, on behalf of insurance carriers, stayed certain liens held by Mesa which accounted for a reduction in the net realizable value of the portfolio. As a result, the Company adjusted the net realizable value of the portfolio at September 30, 2019 to $11,014,473.

    Pursuant to an order of the Workers’ Compensation Appeals Board, issued on January 21, 2020, the stays were lifted last week. As a result, Mesa and its collection company have resumed collections and have already begun to receive payments.

    Collection activity will continue while the company pursues permanent relief from the Workers’ Compensation Appeals Board.

    More updates to come!
     
  6. Giants1967

    Giants1967 Member

    Joined:
    Dec 2, 2019
    Messages:
    502
    Likes Received:
    4
    Praxsyn (OTC: PXYN, the “Company”) is pleased to announce that it has a large number of N95 masks, capable of protecting wearers from inhaling viruses, including the COVID-19 Coronavirus available for order.

    As COVID-19 infections spreads and deaths continue to rise, hundreds of millions of surgical masks are being used every single day by everyday people as the worldwide demand continues to surge. Prices continue to spiral upwards and supplies are almost nonexistent.

    Although masks are available in fewer and fewer numbers, with suppliers raising prices faster than buyers can keep up, masks that we have located for others are now priced beyond their reach. Utilizing a worldwide network, Praxsyn has created a direct pipeline from manufacturers and suppliers to buyers giving those that qualify, the fairest price on the market. To that end, Praxsyn (PXYN) is offering wholesale masks, on a first come, first served basis to qualified buyers, so long as supplies last. Any interested parties should contact us at: [email protected]

    Frank Brady, CEO of Praxsyn commented, “With the rapid spread of this virus, prices that were high one week ago, are low, compared to what suppliers are now willing to sell masks for. Any potential buyers that wish to attempt to buy N95 masks or similar in bulk should contact Praxsyn at [email protected]. Minimum quantities are currently limited to orders over 100,000 units and payment must be by wire transfer or letter of credit.”

    Legal Disclaimer: All mask availability is subject to prior sale. No guarantee can be made that supplies will continue to be available or that prices will not increase at any time.

    More updates to come!
     

Share This Page